Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USA.
Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USA.
Ultrasound Med Biol. 2024 Dec;50(12):1854-1860. doi: 10.1016/j.ultrasmedbio.2024.08.010. Epub 2024 Sep 5.
To assess the ability of the pressure gradient between breast lesions and adjacent normal tissue estimated by 3D subharmonic-aided pressure estimation (SHAPE) to characterize indeterminate breast lesions.
This prospective study enrolled patients scheduled for ultrasound-guided needle biopsies of a breast lesion. Before the biopsy, 3D SHAPE data were collected from the breast lesion during the infusion of an ultrasound contrast agent (Definity) as well as after clearance of the agent. Direct, invasive pressure measurements in the lesion and adjacent normal tissue were then obtained using an intracompartmental pressure monitoring system (C2DX) before tissue sampling as part of the biopsy procedure. The mean SHAPE gradient and invasive measurement gradient between the lesion and adjacent normal tissue were compared to the biopsy results. The SHAPE gradients were also compared to the invasive pressure gradients.
There were 8 malignant and 13 benign lesions studied. The SHAPE gradients and invasive pressure gradients were significantly different between the benign and malignant lesions (2.86 ± 3.24 vs. -0.03 ± 1.72 a.u.; p = 0.03 and 9.9 ± 8.5 vs. 20.9 ± 8.0 mmHg; p = 0.008, respectively). The area under the curves, specificities, and sensitivities for detecting malignancy by SHAPE gradients and invasive pressure gradients were 0.79 and 0.88, 77% and 92%, and 88% and 50%, respectively. A weak negative correlation was found between the SHAPE and invasive pressure gradients (r = -0.2).
The pressure gradient between a breast lesion and adjacent normal tissue estimated by 3D SHAPE shows potential for characterizing indeterminate breast lesions.
评估通过 3D 次谐波辅助压力估计(SHAPE)估计的乳腺病变与相邻正常组织之间的压力梯度来对不确定乳腺病变进行特征描述的能力。
本前瞻性研究纳入了计划接受超声引导下乳腺病变穿刺活检的患者。在活检前,在向病变部位输注超声造影剂(Definity)以及造影剂清除后,从病变部位采集 3D SHAPE 数据。在组织取样前,通过腔内压力监测系统(C2DX)直接在病变部位和相邻正常组织内进行侵入性压力测量,这是活检程序的一部分。将病变和相邻正常组织之间的平均 SHAPE 梯度和侵入性测量梯度与活检结果进行比较。还将 SHAPE 梯度与侵入性压力梯度进行了比较。
共研究了 8 个恶性病变和 13 个良性病变。良性和恶性病变之间的 SHAPE 梯度和侵入性压力梯度差异有统计学意义(2.86±3.24 与-0.03±1.72 a.u.;p=0.03 和 9.9±8.5 与 20.9±8.0 mmHg;p=0.008)。SHAPE 梯度和侵入性压力梯度检测恶性病变的曲线下面积、特异性和敏感性分别为 0.79 和 0.88、77%和 92%、88%和 50%。SHAPE 和侵入性压力梯度之间存在弱负相关(r=-0.2)。
通过 3D SHAPE 估计的乳腺病变与相邻正常组织之间的压力梯度具有对不确定乳腺病变进行特征描述的潜力。